Somatodendritic (STD) dopamine (DA) release is a key mechanism for the autoregulatory control of DA release in the brain. However, its molecular mechanism remains undetermined. We tested the hypothesis that differential expression of synaptotagmin (Syt) isoforms explains some of the differential properties of terminal and STD DA release. Down-regulation of the dendritically expressed Syt4 and Syt7 severely reduced STD DA release, whereas terminal release required Syt1. Moreover, we found that although mobilization of intracellular Ca 2؉ stores is inefficient, Ca 2؉ influx through N-and P/Q-type voltage-gated channels is critical to trigger STD DA release. Our findings provide an explanation for the differential Ca 2؉ requirement of terminal and STD DA release. In addition, we propose that not all sources of intracellular Ca 2؉ are equally efficient to trigger this release mechanism. Our findings have implications for a better understanding of a fundamental cell biological process mediating transcellular signaling in a system critical for diseases such as Parkinson disease.
Dopamine (DA),4 like other monoamine neurotransmitters, is released from the cell body and dendrites in addition to axon terminals (1). This process, called somatodendritic (STD) release, is important in the ventral tegmental area (VTA) for induction of behavioral sensitization to amphetamine through activation of local D1 receptors (2, 3) and in the substantia nigra (SN) for control of motor performance (4, 5). In addition, STD DA release modulates DA neuron firing activity through D2 autoreceptor activation (6, 7) and increases firing activity of SN pars reticulata ␥-aminobutyric acid-releasing neurons, a process that might activate feedback signals regulating DA neuron activity (8), thereby influencing axonal DA release.Two mechanisms have been proposed to mediate STD DA release: reversal of the DA transporter (9) and a vesicular exocytotic-like mechanism. In agreement with the second mechanism, STD DA release is activity-dependent (6, 10), sensitive to depletion of vesicular stores with reserpine (6, 11, 12), and Ca 2ϩ -dependent (6, 10, 12, 13). Moreover, disruption of SNARE proteins with botulinum toxins blocks STD DA release (10, 13). Vesicular exocytosis requires the concerted action of SNARE proteins and a synaptotagmin (Syt). During release, SNAREs have a direct role in vesicle-membrane fusion, and Syt acts as a Ca 2ϩ sensor. Of the 15 Syt isoforms identified so far, Syt1, 2, 3, 5, 6, 7, 9, and 10 have been reported to drive Ca 2ϩ -dependent vesicular fusion (14), and only Syt1, 2, and 9 are confirmed as Ca 2ϩ sensors for synaptic neurotransmitter release from axon terminals (15).One of the hallmarks of STD DA release is its relative persistence at reduced levels of extracellular Ca 2ϩ concentrations: although release from axon terminals is drastically reduced at extracellular Ca 2ϩ levels lower than 1 mM, STD DA release persists at Ca 2ϩ levels between 0.5 and 1 mM (Refs. 10, 12, and 13; but see also Ref. 16). This differential Ca 2...